1,199 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Monday’s Close
AGN Allergan plc. $184.29 $62.56B Downtrend
Article Searches
What's in Store for Centene (CNC) This Earnings Season? http://www.zacks.com/stock/news/329257/whats-in-store-for-centene-cnc-this-earnings-season?cid=CS-ZC-FT-329257 Oct 18, 2018 - Centene's (CNC) third quarter should exhibit strong performances by its Government-backed and Medicaid businesses.
EyePoint (EYPT) Gets FDA Approval for Eye Therapy Yutiq http://www.zacks.com/stock/news/328751/eyepoint-eypt-gets-fda-approval-for-eye-therapy-yutiq?cid=CS-ZC-FT-328751 Oct 17, 2018 - EyePoint (EYPT) gains an FDA approval for its eye therapy Yutiq to help cure chronic non-infectious uveitis affecting the posterior segment of the eye.
Can Allergan's Key Drugs, Solid Pipeline Abate Generic Woes? http://www.zacks.com/stock/news/328547/can-allergans-key-drugs-solid-pipeline-abate-generic-woes?cid=CS-ZC-FT-328547 Oct 17, 2018 - Allergan (AGN) is facing loss of exclusivity for many blockbuster products. However, drugs like Botox/Linzess, new drugs and cost cuts can shield it from potential sales drop.
Healthcare 16-24% Target Net Gains Pace WallStars For October https://seekingalpha.com/article/4211623-healthcare-16minus-24-percent-target-net-gains-pace-wallstars-october?source=feed_all_articles Oct 15, 2018 - Big pharma drug makers and biotech continued to top the healthcare sector by broker targets. WallStars are distinguished by positive broker target price upsides.The Healthcare sector is comprised of 1
VistaGen: Expensive At 12x Its Book Value Per Share https://seekingalpha.com/article/4210659-vistagen-expensive-12x-book-value-per-share?source=feed_sector_healthcare Oct 09, 2018 - VistaGen is a clinical-stage biopharmaceutical company developing treatments to fight depression and other central nervous system illnesses.With a large target market size and candidates at Phase 2 of
Allergan And Cenicriviroc In NASH Fibrosis: Revisiting FDA Guidelines For Conditional Approval https://seekingalpha.com/article/4209609-allergan-cenicriviroc-nash-fibrosis-revisiting-fda-guidelines-conditional-approval?source=feed_sector_healthcare Oct 03, 2018 - Allergan generates increasing revenues.Its NASH franchise is also progressing satisfactorily with the AURORA Phase 3 NASH trial interim data readout anticipated H1/2019.Clinically, cenicriviroc has sh
Paratek (PRTK) Gets FDA Approval for Nuzyra and Seysara http://www.zacks.com/stock/news/326044/paratek-prtk-gets-fda-approval-for-nuzyra-and-seysara?cid=CS-ZC-FT-326044 Oct 03, 2018 - Paratek (PRTK) gets FDA approval for Nuzyra for the treatment of serious community-acquired bacterial infections and Seysara for the treatment of acne.
Pharma Stock Roundup: PFE, LLY Get Approval for New Drugs, Novartis to Cut Jobs http://www.zacks.com/stock/news/325440/pharma-stock-roundup-pfe-lly-get-approval-for-new-drugs-novartis-to-cut-jobs?cid=CS-ZC-FT-325440 Sep 28, 2018 - FDA grants approval to Lilly's (LLY) Emgality for migraine and Pfizer's (PFE) Vizimpro for an advanced lung cancer indication. Novartis (NVS) to cut more than 2,000 jobs in Switzerland and U.K
Tiziana Life Sciences Plans To Raise $16 Million In U.S. IPO https://seekingalpha.com/article/4208671-tiziana-life-sciences-plans-raise-16-million-u-s-ipo?source=feed_tag_ipo_analysis Sep 27, 2018 -
Eton Pharmaceuticals Readies Plan For $18 Million IPO https://seekingalpha.com/article/4208649-eton-pharmaceuticals-readies-plan-18-million-ipo?source=feed_tag_ipo_analysis Sep 27, 2018 - Eton Pharmaceuticals has filed proposed terms to sell $18 million in common stock in an IPO.The firm is attempting to reformulate existing, approved treatments to reduce costs and improve patient adhe

Pages: 123456...120

Page 1>

Related Companies

Name Exchange Price Mkt Cap
CELG Celgene Corporation NASDAQ $87.23 $61.35B
SHPG Shire plc NASDAQ $176.25 $46.08B
VRTX Vertex Pharmaceuticals Incorporated NASDAQ $175.8 $44.93B
ZTS Zoetis Inc. NYSE $88.3 $42.55B
REGN Regeneron Pharmaceuticals, Inc. NASDAQ $386.665 $41.78B
Sector: Health Care > Industry: Major Pharmaceuticals
DeepLinks for Allergan plc.